| Keywords: |
t lymphocyte; t-lymphocytes; editorial; tumor lysis syndrome; dna modification; graft versus host reaction; cell therapy; adoptive transfer; caspase 9; thymidine kinase; pluripotent stem cell; hematopoietic stem cell; genetic disorder; bone marrow transplantation; graft vs host disease; graft versus leukemia effect; severe combined immunodeficiency; immunotherapy, adoptive; degenerative disease; genotoxicity; organic chemicals; genes, transgenic, suicide; monogenic disorder; tacrolimus binding proteins
|
